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It has been known in the community studying the pathogenesis 
of Streptococcus pyogenes that spontaneous mutation occurs 
during passages in laboratory media or in animals, so some of the 
progeny’s virulence can be changed, mainly due to the change 
of the expression of virulence factors.1-3 This phenomenon is not 
only limited to S. pyogenes, but also happens to other pathogens.4-6 
Like other pathogens, S. pyogenes, a strict human pathogen, 
produces virulence factors to attach to and invade host tissues, 
avoid the immune system, or degrade or kill host tissues and 
cells. These virulence factors are necessary to colonize, invade, 
and spread in the host. However, some of these factors are not 
necessary to grow in laboratory media, so reduced expression of 
these virulence factors could increase the fitness for growth in 
laboratory media. A notorious S. pyogenes virulence factor whose 
expression changes during passages in the laboratory is M protein. 
M protein is a cell wall-anchored protein with a coiled-coil 
structure and its important role in S. pyogenes pathogenesis has 
long been recognized as an adhesin and antiphagocytic factor.7 
It is also the causative molecule of the streptococcal rheumatic 
heart disease. The antibodies generated against M protein cross 
react with tissues in the heart valves.8 Thus, when S. pyogenes 
loses M protein, its virulence is dramatically attenuated in animal 
infection models.
It has been a puzzle in the study of S. pyogenes whether 
or not the sagA/pel locus influences the expression of the 
M protein gene (emm). Several studies on the sagA/pel locus 
produced conflicting results on the regulation of M protein 
gene expression. However, the recent study by Zhou et al. 
in this issue of Virulence shows that the sagA/pel locus does 
not regulate the expression of M protein at least in the M1 
strains that most studies for the sagA/pel locus used, and the 
confusion has been caused by secondary spurious mutations 
during mutagenesis.9 This study by Zhou et al. reminds us 
of the importance of awareness of spontaneous mutation or 
phase variation possibilities during mutagenesis of S. pyogenes. 
During laboratory passages, the expression of other virulence 
factors such as capsule and the protease SpeB changes,3 so this 
phenomenon seems not to be limited to M protein.
Recent genomic studies show that genetic changes in 
S. pyogenes occur not only during passages in the laboratory (in 
vitro passage) but also during infection (in vivo passage).10-13 
Interestingly, these genetic changes are selected mostly in the 
virulence factor-regulator genes of mga, covRS, and ropB. In the 
study by Zhou et al., the expression of both genes of M protein 
and its regulator Mga decreased in strains producing low levels 
of M protein after lab passages, and there was no mutation in the 
emm and mga promoter region. However, since the expression 
of mga is autoregulated,14 it cannot be ruled out that Mga was 
mutated in the study. The major virulence factors regulated by 
Mga, CovRS, and RopB are M protein, capsule, and SpeB, which 
are the same virulence factors whose expression was changed after 
laboratory passages. Therefore, the selected mutations during in 
vitro passages might also be concentrated in these regulators.
To prevent improper interpretation of a function attributed to 
a gene due to spurious secondary mutations, mutagenesis should 
be carefully performed and the phenotype of mutants should 
be carefully examined. S. pyogenes starts to die quickly after 
reaching the stationary phase in THY medium (most popular lab 
medium for S. pyogenes) probably due to the lack of nutrients, low 
pH (~pH 5.5) etc. It has been known that cells go through more 
mutation during conditions not favorable for growth such as in 
the stationary phase.15,16 Thus, during mutagenesis, cells should 
not stay in the stationary phase too long. After mutagenesis, the 
phenotype of several mutant colonies, not just one or two, should 
be examined. The expression of the virulence factors M protein, 
capsule, and SpeB can be easily examined phenotypically. The 
production level of capsule is easily determined by the appearance 
and size of colonies on agar plates. The expression level of the 
major secreted protease SpeB can be examined by plating cells 
on skim milk agar plates.17 Most, if not all, S. pyogenes strains 
form aggregates during stationary phase in liquid media, and 
M protein is involved in the aggregate formation through 
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homophilic protein–protein interactions.18 However, other cell 
surface proteins such as M-like proteins, Protein H, and Protein 
F are also responsible for the aggregation. Thus, it is wise not to 
pick non-aggregated colonies if other colonies are aggregated in 
liquid media. However, when the expression of M protein needs 
to be tested, a direct method such as western blotting should be 
performed.
Another way to confirm the function of a gene attributed 
after mutagenesis is to perform the complementation test. Most 
commonly, multicopy plasmids are used to complement a gene or 
genes in S. pyogenes. Complementation with a multicopy plasmid 
is easy to perform, and if it works, the gene can be manipulated 
easily by deleting a motif or changing key amino acids through 
inverse PCR. However, complementation with a multicopy 
plasmid does not work in some cases, perhaps due to the issues 
of the level or the location of expression. Another way to perform 
complementation is to insert the same gene using a suicide vector 
into the mutagenized site. If an intact gene is introduced into 
the original site in the chromosome, then the problems of copy 
number and expression location can be solved. Using this method, 
we succeeded in complementing genes whose complementation 
with a multicopy plasmid did not work.17,19 Previously, McShan 
et al. developed a streptococcus suicide vector system that is 
capable of site-specific integration.20 This vector system contains 
S. pyogenes phage genes to facilitate the vector’s integration into a 
serine tRNA gene, so this system can also be a useful system for 
complementation with a single copy gene.
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